1. Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer. NCT01576172. ClinicalTrials.gov.
2. An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies. NCT02854436. ClinicalTrials.gov.
3. A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer. NCT02059213. ClinicalTrials.gov.
4. A Phase II Study of Palbociclib, A CDK4/6 Inhibitor, in Patients With Metastatic Castration-Resistant Prostate Cancer NCT02905318. ClinicalTrials.gov. Canadian Cancer Trials Group.
5. A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON2). NCT02952534. ClinicalTrials.gov.